» Articles » PMID: 17614360

Partial Derivative-based Sensitivity Analysis of Models Describing Target-mediated Drug Disposition

Overview
Journal AAPS J
Specialty Pharmacology
Date 2007 Jul 7
PMID 17614360
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Sensitivity analysis is commonly used to characterize the effects of parameter perturbations on model output. One use for the approach is the optimization of an experimental design enabling estimation of model parameters with improved accuracy. The primary objective of this study is to conduct a sensitivity analysis of selected target-mediated pharmacokinetic models, ascertain the effect of parameter variations on model predictions, and identify influential model parameters. One linear model (Model 1, control) and 2 target-mediated models (Models 2 and 3) were evaluated over a range of dose levels. Simulations were conducted with model parameters being perturbed at the higher and lower ends from literature mean values. Profiles of free plasma drug concentrations and their partial derivatives with respect to each parameter vs time were analyzed. Perturbations resulted in altered outputs, the extent of which reflected parameter influence. The model outputs were highly sensitive to perturbations of linear disposition parameters in all 3 models. The equilibrium dissociation constant (K(D)) was less influential in Model 2 but was influential in the terminal phase in Model 3, highlighting the role of K(D) in this region. An equation for Model 3 in support of the result for K(D) was derived. Changes in the initial receptor concentration [R(tot) (0)] paralleled the observed effects of initial plasma volume (V(c)) perturbations, with increased influence at higher values. Model 3 was also sensitive to the rates of receptor degradation and internalization. These results suggest that informed sampling may be essential to accurately estimate influential parameters of target-mediated models.

Citing Articles

Two new user-friendly methods to assess pharmacometric parameter identifiability on categorical and continuous scales.

van Noort M, Ruppert M CPT Pharmacometrics Syst Pharmacol. 2024; 13(7):1160-1169.

PMID: 38715388 PMC: 11247123. DOI: 10.1002/psp4.13147.


Navigating the landscape of parameter identifiability methods: A workflow recommendation for model development.

van Noort M, Ruppert M, DeJongh J, Marostica E, Bosch R, Mesic E CPT Pharmacometrics Syst Pharmacol. 2024; 13(7):1170-1179.

PMID: 38715385 PMC: 11247124. DOI: 10.1002/psp4.13148.


Uncertainty-aware automated assessment of the arm impedance with upper-limb exoskeletons.

Tesfazgi S, Sangouard R, Endo S, Hirche S Front Neurorobot. 2023; 17:1167604.

PMID: 37692885 PMC: 10490610. DOI: 10.3389/fnbot.2023.1167604.


Article Application of neural network in metal adsorption using biomaterials (BMs): a review.

Nighojkar A, Zimmermann K, Ateia M, Barbeau B, Mohseni M, Krishnamurthy S Env Sci Adv. 2023; 2(1):11-38.

PMID: 36992951 PMC: 10043827. DOI: 10.1039/d2va00200k.


Normalized sensitivity of multi-dimensional body composition biomarkers for risk change prediction.

Criminisi A, Sorek N, Heymsfield S Sci Rep. 2022; 12(1):12375.

PMID: 35858946 PMC: 9300600. DOI: 10.1038/s41598-022-16142-1.


References
1.
Hamby D . A review of techniques for parameter sensitivity analysis of environmental models. Environ Monit Assess. 2013; 32(2):135-54. DOI: 10.1007/BF00547132. View

2.
VARKONYI P, Bruckner J, Gallo J . Effect of parameter variability on physiologically-based pharmacokinetic model predicted drug concentrations. J Pharm Sci. 1995; 84(3):381-4. DOI: 10.1002/jps.2600840322. View

3.
Wu G . Sensitivity analysis of pharmacokinetic parameters in one-compartment models. Pharmacol Res. 2000; 41(4):445-53. DOI: 10.1006/phrs.1999.0602. View

4.
Mager D, Jusko W . General pharmacokinetic model for drugs exhibiting target-mediated drug disposition. J Pharmacokinet Pharmacodyn. 2002; 28(6):507-32. DOI: 10.1023/a:1014414520282. View

5.
Nestorov I . Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models. J Pharmacokinet Biopharm. 2001; 27(6):577-96. DOI: 10.1023/a:1020926525495. View